Skip to main content
. 2024 Feb 29;2:16. doi: 10.1038/s44276-024-00037-x

Table 2.

Cytokine levels in detergent-treated sEV from HNSCC patients and HDs.

Protein Patients, N (%) ≥ LLOQ (Ntotal = 30) HDs, N (%) ≥ LLOQ (Ntotal = 10) Patients, mean (± sd) HDs, mean (± sd) P valuea
APRIL 29 (96.7) 9 (90) 633.7 ( ± 1186.52) 15.47 ( ± 24.94) 0.003
BAFF 7 (23.3) 0 (0) 2.2 ( ± 1.4) ND
BCL (CXCL13) 29 (96.7) 9 (90) 68.57 ( ± 350.81) 1.55 ( ± 1.48) 0.35
CD30 30 (100) 9 (90) 17.17 ( ± 54.38) 22.63 ( ± 59.42) 0.24
CD40L 30 (100) 9 (90) 56.66 ( ± 139.14) 52.31 ( ± 99.39) 0.34
ENA-78 (CXCL5) 25 (83.3) 7 (70) 0.03 ( ± 0.05) 0.005 ( ± 0.005) 0.02
Eotaxin (CCL11) 30 (100) 10 (100) 0.44 ( ± 1.31) 1.82 ( ± 0.83) <.0001
Eotaxin-2 (CCL24) 30 (100) 10 (100) 13.7 ( ± 12.29) 28.24 ( ± 12.39) 0.002
Eotaxin-3 (CCL26) 19 (63.3) 5 (50) 0.38 ( ± 0.62) 0.03 ( ± 0.03) 0.02
FGF-2 22 (73.3) 5 (50) 0.04 ( ± 0.07) 0.005 ( ± 0.004) 0.01
Fractalkine (CX3CL1) 27 (90) 9 (90) 15.34 ( ± 25.98) 0.45 ( ± 0.35) 0.002
G-CSF (CSF-3) 30 (100) 10 (100) 0.4 ( ± 0.58) 0.13 ( ± 0.15) 0.02
GM-CSF 26 (86.7) 8 (80) 0.49 ( ± 0.91) 0.51 ( ± 1.09) 0.33
GRO alpha (CXCL1) 14 (46.7) 0 (0) 0.09 ( ± 0.09) ND
HGF 29 (96.7) 10 (100) 0.37 ( ± 0.38) 0.22 ( ± 0.16) 0.38
IFNa 30 (100) 10 (100) 0.04 ( ± 0.04) 0.02 ( ± 0.02) 0.052
IFNg 21 (70) 3 (30) 3.73 ( ± 5.11) 0.35 ( ± 0.13) 0.07
IL-10 5 (16.7) 1 (10) 0.12 ( ± 0.13) 0.73 ( ± 0) 0.23
IL-12p70 30 (100) 10 (100) 0.1 ( ± 0.29) 0.03 ( ± 0.03) 0.04
IL-13 30 (100) 10 (100) 0.05 ( ± 0.06) 0.02 ( ± 0.02) 0.2
IL-15 30 (100) 10 (100) 4.03 ( ± 19.65) 2.22 ( ± 5.05) 0.58
IL-16 30 (100) 10 (100) 0.07 ( ± 0.05) 0.04 ( ± 0.02) 0.007
IL-17a (CTLA-8) 17 (56.7) 4 (40) 71.33 ( ± 279.71) 1.71 ( ± 2.44) 0.93
IL-18 30 (100) 10 (100) 0.09 ( ± 0.08) 0.06 ( ± 0.05) 0.13
IL-1a 29 (96.7) 7 (70) 7.61 ( ± 14.6) 3.03 ( ± 7.01) 0.08
IL-1b 22 (73.3) 1 (10) 0.21 ( ± 0.32) 0.05 ( ± 0) 0.71
IL-2 29 (96.7) 9 (90) 6.74 ( ± 32.21) 0.65 ( ± 1.38) 0.52
IL-20 30 (100) 9 (90) 3.4 ( ± 9.83) 2.7 ( ± 5.42) 0.14
IL-21 28 (93.3) 9 (90) 612.78 ( ± 1228.1) 5.47 ( ± 10.33) 0.002
IL-22 28 (93.3) 9 (90) 82.16 ( ± 153.16) 1.98 ( ± 3.5) 0.0004
IL-23 3 (10) 0 (0) 7.29 ( ± 9.6) ND
IL-27 23 (76.7) 5 (50) 16.76 ( ± 42.84) 1.7 ( ± 1.18) 0.7
IL-2R 15 (50) 1 (10) 12.1 ( ± 16.77) 0.01 ( ± 0) 0.13
IL-3 29 (96.7) 9 (90) 74.59 ( ± 151.66) 26.31 ( ± 72.27) 0.02
IL-31 11 (36.7) 0 (0) 7.66 ( ± 16.56) ND
IL-4 13 (43.3) 0 (0) 1.83 ( ± 2.57) ND
IL-5 9 (30) 2 (20) 3.17 ( ± 7.09) 1.24 ( ± 1.15) 0.91
IL-6 28 (93.3) 8 (80) 5.35 ( ± 26.92) 0.12 ( ± 0.2) 0.21
IL-7 28 (93.3) 10 (100) 0.09 ( ± 0.28) 0.08 ( ± 0.18) 0.38
IL-8 21 (70) 3 (30) 7.36 ( ± 31.2) 0.78 ( ± 0.51) 0.6
IL-9 20 (66.7) 0 (0) 0.24 ( ± 0.79) ND
IP-10 26 (86.7) 0 (0) 1.98 ( ± 7.28) ND
I-TAC (CXCL11) 29 (96.7) 9 (90) 6259.65 ( ± 26683.78) 44.63 ( ± 117.18) 0.055
LIF 30 (100) 10 (100) 0.66 ( ± 2.82) 0.09 ( ± 0.07) 0.46
MCP-1 4 (13.3) 3 (30) 0.06 ( ± 0.05) 0.03 ( ± 0.02) 1
MCP-2 30 (100) 10 (100) 0.09 ( ± 0.22) 0.31 ( ± 0.73) 0.25
MCP-3 30 (100) 9 (90) 9.5 ( ± 44.45) 1.21 ( ± 2.67) 0.04
M-CSF 6 (20) 0 (0) 5.03 ( ± 3.88) ND
MDC 28 (93.3) 8 (80) 5.44 ( ± 9.88) 1.04 ( ± 1.01) 0.003
MIF 30 (100) 9 (90) 0.1 ( ± 0.1) 0.27 ( ± 0.19) 0.004
MIG 23 (76.7) 3 (30) 1042.18 ( ± 1678.7) 1.57 ( ± 2.19) 0.03
MIP-1a 30 (100) 10 (100) 1.18 ( ± 2.22) 1.73 ( ± 2.35) 0.41
MIP-1b 28 (93.3) 10 (100) 3.11 ( ± 4.76) 1.7 ( ± 4.61) 0.008
MIP-3a 30 (100) 10 (100) 1.2 ( ± 2.4) 0.36 ( ± 0.4) 0.09
MMP-1 18 (60) 10 (100) 0.14 ( ± 0.12) 0.47 ( ± 0.44) 0.01
NGFb 18 (60) 1 (10) 0.32 ( ± 0.43) 0.02 ( ± 0) 0.17
SCF 30 (100) 10 (100) 0.03 ( ± 0.03) 0.01 ( ± 0.009) 0.07
SDF-1a 26 (86.7) 7 (70) 23586.44 ( ± 73394.65) 327.73 ( ± 765.69) 0.01
TNFa 30 (100) 10 (100) 0.12 ( ± 0.25) 0.05 ( ± 0.07) 0.17
TNFb 7 (23.3) 0 (0) 7.84 ( ± 18.11) ND
TNFRII 29 (96.7) 10 (100) 5.76 ( ± 9.17) 3.34 ( ± 9.57) 0.03
TRAIL 22 (73.3) 7 (70) 83.17 ( ± 136.2) 94.9 ( ± 229) 0.12
TSLP 30 (100) 9 (90) 62.81 ( ± 198.44) 58.41 ( ± 147.88) 0.2
TWEAK 30 (100) 10 (100) 3431.98 ( ± 13531.36) 7344.54 ( ± 14747.09) 0.48
VEGF-A 30 (100) 10 (100) 194.21 ( ± 390.15) 111.65 ( ± 328.85) 0.006

aWilcoxon-Mann-Whitney test. ND not detected.